Therapeutic high affinity T cell receptor targeting a KRAS(G12D) cancer neoantigen

Neoantigens derived from somatic mutations are specific to cancer cells and are ideal targets for cancer immunotherapy. KRAS is the most frequently mutated oncogene and drives the pathogenesis of several cancers. Here we show the identification and development of an affinity-enhanced T cell receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Poole, Andrew, Karuppiah, Vijaykumar, Hartt, Annabelle, Haidar, Jaafar N., Moureau, Sylvie, Dobrzycki, Tomasz, Hayes, Conor, Rowley, Christopher, Dias, Jorge, Harper, Stephen, Barnbrook, Keir, Hock, Miriam, Coles, Charlotte, Yang, Wei, Aleksic, Milos, Lin, Aimee Bence, Robinson, Ross, Dukes, Joe D., Liddy, Nathaniel, Van der Kamp, Marc, Plowman, Gregory D., Vuidepot, Annelise, Cole, David K., Whale, Andrew D., Chillakuri, Chandramouli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464187/
https://www.ncbi.nlm.nih.gov/pubmed/36088370
http://dx.doi.org/10.1038/s41467-022-32811-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464187/
https://www.ncbi.nlm.nih.gov/pubmed/36088370
http://dx.doi.org/10.1038/s41467-022-32811-1

Ejemplares similares